CancerWorld

🎗️ Pediatric oncology has transformed what it means to survive childhood cancer. Now, the challenge is to transform what comes after survival.

The September issue of CancerWorld asks what progress should look like when survival alone is no longer enough.

🌍 Building cancer care capacity where children still struggle to reach treatment.
🔬 Reducing the long-term consequences of life-saving therapies.
❤️ Protecting childhood, family life and the future beyond cancer.

From Cyprus, Mozambique and Tanzania to new research, survivorship and patient perspectives, new issue brings together the science, systems and stories shaping the next chapter of pediatric oncology.

Because the goal is not only to help children survive cancer, but to protect the life they still have ahead of them.

📖 Explore the new issue here: cancerworld.net/wp-content/upl…

@oncodaily | @DrLoizos | @AsiaSiop | @ServierPharma | @Servier | @DanaBryson11 | @IntChildCancer | @WChildCancer | @vickyyyf | @CesaltinaLoren |
@AORTIC_AFRICA

💙 The scan showed stable disease. But what mattered most to the patient was something no scan could measure.

“Doctor, can I have two extra weeks before my next chemotherapy? My son is getting married. I want to be in shape for his wedding.”

For Dr Imène Hadji, an oncologist in Algeria, this question became a powerful reminder of what patient-centred care truly means.

🩺 Behind every diagnosis is a person with hopes, priorities and moments worth protecting.

In her article Dr Hadji reflects on how listening, empathy and seemingly small clinical decisions can make an extraordinary difference.

🏆 “What the Scan Couldn't Tell Me,” is one of the two winning entries of the ESO College Voices Contest 2026, a collaboration between the European School of Oncology and CancerWorld.

Because treating cancer is about more than controlling disease. It is also about protecting the life patients are fighting to live.

📖 Read the full article here: lnkd.in/eGc_ZNmJ

@oncodaily | @ESOncology

🇺🇦 In Lviv, where hospitals care for patients with devastating injuries and life-threatening infections, clinicians are demonstrating that scientific excellence does not have to wait for peace.

🔬 At First Lviv Territorial Medical Union, a randomized Phase 2 trial is investigating an experimental cell therapy for acute respiratory distress syndrome (ARDS), one of critical care's most challenging conditions.

This is more than a story about a clinical trial. It is about resilience, scientific ambition and the determination to build lasting research capacity in the midst of war.

In CancerWorld, Thiago Favano shares what he discovered in Lviv—and why the experience profoundly changed his understanding of what is possible under extraordinary circumstances.

💙💛 They came to advance research. They left with a lesson in courage, commitment and humanity.

📖 Read “Building a Clinical Trial in a Country at War: What Lviv Taught Us” here: cancerworld.net/building-a-cli…

@oncodaily | @ThiagoFavano

🔬 89% of highly accomplished women scientists faced gender-related barriers—even after reaching the highest levels of medical research.

A study of 82 leading Italian women scientists reveals a striking reality:
▪️ 89% encountered gender-related obstacles.
▪️ 57% reported difficulties accessing leadership positions.
▪️ Nearly three-quarters experienced burnout.

Their success did not mean the barriers had disappeared. It meant they had succeeded despite them.

In CancerWorld, Prof. Adriana Albini, Editor-in-Chief, examines what these findings reveal about scientific leadership, institutional culture and the changes needed to achieve genuine equality.

💡 The next generation of women scientists should not have to be exceptional simply to overcome the system.

📖 Read “When Success Is Not Enough: Why Women Still Face Barriers at the Top of Medical Research” here: cancerworld.net/when-success-i…

@oncodaily | @adrianaalbini1

⏳ Cancer does not wait. Yet too many patients are still waiting for progress to reach them.

For Antonella Cardone, CEO of Cancer Patients Europe, this urgency is deeply personal.

Her journey has taken her from advocating for patients to caring for loved ones with cancer and experiencing the vulnerabilities of being a patient herself. Each perspective has reinforced a fundamental truth:

“Every patient is unique. So, there is no standard patient, no standard decisions.”

In this interview, Cardone confronts one of Europe's greatest cancer care challenges: scientific innovation is advancing faster than patients' access to it.

From unequal access to treatment to the need for genuine patient involvement, her message is clear: “Time is of essence.”

💡 Because for patients, delayed progress is not just a policy failure. It is time taken from their lives.

📖 Read the full interview by Knarik Arakelyan here: cancerworld.net/time-is-of-ess…

@oncodaily | @CancerPatientsE